P. Kanikarla

发表

Resistance Mechanisms to Anti–Epidermal Growth Factor Receptor Therapy in RAS/RAF Wild-Type Colorectal Cancer Vary by Regimen and Line of Therapy

J. Shen, S. Kopetz, T. Troiani, 2022 .

KRASG12C-independent feedback activation of wild-type RAS constrains KRASG12C inhibitor efficacy

Fengqin Gao, S. Kopetz, A. Sorokin, 2022, Cell reports.

Obestatin stimulates glucose-induced insulin secretion through ghrelin receptor GHS-R

S. Samson, Shaodong Guo, Yuxiang Sun, 2017, Scientific Reports.

Antitumor Efficacy of Dual Blockade with Encorafenib + Cetuximab in Combination with Chemotherapy in Human BRAFV600E-Mutant Colorectal Cancer

L. Altucci, J. Tabernero, S. Kopetz, 2023, Clinical cancer research : an official journal of the American Association for Cancer Research.